Macrocyclic compounds as ROS1 kinase inhibitors Grant US-10966985-B2 United States of America 06 Apr 2021
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10907215-B2 United States of America 02 Feb 2021
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Grant US-10724102-B2 United States of America 28 Jul 2020
Macrocylic compounds as ROS1 kinase inhibitors Grant US-10688100-B2 United States of America 23 Jun 2020